Dimensional Fund Advisors
TOVX icon

Dimensional Fund Advisors’s Theriva Biologics TOVX Stock Holding History

Dimensional Fund Advisors’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3
Closed -$82K – 3374
2015
Q2 		$82K Buy
+3
New +$60.2K ﹤0.01% 3315
2014
Q1 		– Sell
-2
Closed -$22K – 3599
2013
Q4 		$22K Hold
2
– – ﹤0.01% 3465
2013
Q3 		$25K Hold
2
– – ﹤0.01% 3486
2013
Q2 		$26K Buy
+2
New +$27.3K ﹤0.01% 3478

Other funds holding TOVX

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's TOVX Position: Q3 2015 in Review

Dimensional Fund Advisors sold out of Theriva Biologics (TOVX) in Q3 2015, closing a stake of 3 shares — an estimated $82K sold.

Dimensional Fund Advisors first reported a position in TOVX in Q2 2013 and held it in 4 quarters. The position peaked at $82K in Q2 2015. 45 funds tracked by Wall St. Rank hold TOVX as of Q3 2015.

  • Dimensional Fund Advisors reported no remaining Theriva Biologics position as of Q3 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 3 Theriva Biologics shares in Q3 2015, an estimated $82K.
  • Dimensional Fund Advisors first reported a position in Theriva Biologics in Q2 2013 and held it in 4 quarters.
  • Dimensional Fund Advisors's Theriva Biologics position peaked at $82K in Q2 2015.
  • 45 funds tracked by Wall St. Rank held Theriva Biologics as of Q3 2015.

Based on Dimensional Fund Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.